project id: TCGA-UCEC; case submitter id: TCGA-A5-A1OH; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.6; age at index: 86; days to birth: -31451; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1924; age at diagnosis: 31451; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1105.0; figo stage: Stage IIIA; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 358; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-A5-A1OH-01A-21; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 1.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0;